Skip to main content
Signal8
Launch Terminal

Alpha Tau Medical Ltd. (DRTS)

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Biotechnology

Alpha Tau Medical Ltd. logo

Alpha Tau Medical Ltd.

NASDAQ:DRTSHealthcare
-1.28%$13.06
AH$13.06+0.00%vs close
Mkt Cap$1.21B
Float63.91M
O/S92.48M
Vol
$ Vol
RVOL
Inst Own8.6%
Earnings
Dilution
Alpha Tau Medical Ltd. logoNASDAQ:DRTS$13.06-1.28%
FormDescription
6-K
REPORT OF FOREIGN PRIVATE ISSUER
6-K
REPORT OF FOREIGN PRIVATE ISSUER
3
6-K
REPORT OF FOREIGN PRIVATE ISSUER
3
6-K
REPORT OF FOREIGN PRIVATE ISSUER
4
4
PRIMARY DOCUMENT
144
Notice of Proposed Sale of Securities
4
PRIMARY DOCUMENT
6-K
REPORT OF FOREIGN PRIVATE ISSUER
5
6-K
REPORT OF FOREIGN PRIVATE ISSUER
2
6-K
REPORT OF FOREIGN PRIVATE ISSUER
4
6-K
REPORT OF FOREIGN PRIVATE ISSUER
2
4
PRIMARY DOCUMENT
144
Notice of Proposed Sale of Securities
4
PRIMARY DOCUMENT
4
PRIMARY DOCUMENT
144
Notice of Proposed Sale of Securities
4
PRIMARY DOCUMENT
144
Notice of Proposed Sale of Securities
4
PRIMARY DOCUMENT
144
Notice of Proposed Sale of Securities
6-K
REPORT OF FOREIGN PRIVATE ISSUER
4
PRIMARY DOCUMENT
6-K
REPORT OF FOREIGN PRIVATE ISSUER
3
144
Notice of Proposed Sale of Securities
6-K
REPORT OF FOREIGN PRIVATE ISSUER
3

1-25 of 239

…

Recent SEC filings with analysis

    Alpha Tau Medical Ltd. (DRTS) SEC Filings: 10-K, 10-Q, 8-K, Form 4 | Signal8